A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects. [electronic resource]
Producer: 20170522Description: 2143-2160 p. digitalISSN:- 1178-2013
- Animals
- Blood Glucose -- metabolism
- Cell Proliferation -- drug effects
- Chitosan -- chemistry
- Diabetes Mellitus, Type 2 -- drug therapy
- Drug Liberation
- Exenatide
- Fasting -- blood
- Glucose -- metabolism
- Half-Life
- Hydrogen Peroxide -- toxicity
- Insulin -- genetics
- Insulin Resistance
- Male
- Mice
- Nanoparticles -- chemistry
- Peptides -- pharmacology
- RNA, Messenger -- genetics
- Reactive Oxygen Species -- metabolism
- Receptor, Insulin -- metabolism
- Receptors, Vasoactive Intestinal Peptide, Type II -- agonists
- Selenium -- chemistry
- Venoms -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.